Abstract
ObjectivesVasoactive drugs have exhibited clinical efficacy in addressing pulmonary arterial hypertension, manifesting a significant reduction in morbidity and mortality. Pulmonary hypertension may complicate advanced interstitial lung disease (PH-ILD) and is...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have